Significant positive association seen after adjustment for age, sex, employment status, BMI, diabetes duration, insulin secretion
WEDNESDAY, Jan. 25, 2023 (HealthDay News) — For adults with type 1 diabetes, there is a significant association between self-stigma and hemoglobin A1c (HbA1c), according to a study published online Jan. 25 in the Journal of Diabetes Investigation.
Shoko Hamano, from Asahi Life Foundation in Tokyo, and colleagues examined the correlation between self-stigma and HbA1c in Japanese people with type 1 diabetes in a cross-sectional study. Outpatients with type 1 diabetes aged 18 years and older completed questionnaires using nine items from the Japanese version of the Self-Stigma Scale.
The final analysis excluding participants with incomplete answers and laboratory data included 109 participants. The researchers found a significant positive association between self-stigma and HbA1c after adjustment for age, sex, employment status, body mass index, duration of diabetes, and insulin secretion (β = 0.05).
“We focused on this issue through clinical experiences with people with type 1 diabetes, whose glycemic management improved markedly by social supports of eliminating diabetes-related stigma. Although the finding of an association between self-stigma and HbA1c is significant, further longitudinal research is required to determine whether self-stigma leads to suboptimal HbA1c,” a coauthor said in a statement. “This research does support and highlight the importance of eliminating self-stigma when treating people with type 1 diabetes.”
Time-Restricted Eating May Help Patients With Type 1 Diabetes
Maternal Diabetes Linked to Increased Risk for Epilepsy in Offspring
Preexisting Medical Conditions Linked to Range of Botox Injection Complications
Diabetes Linked to Increased Risk for Sudden Cardiac Death
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
9 of 10 Leading Causes of Death Unchanged From 2023 to 2024
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors